Lithium-induced Clock Gene Expression in Lymphoblastoid Cells of Bipolar Affective Patients

S Kittel-Schneider,S Schreck,C Ziegler,L Weißflog,M Hilscher,R Schwarz,L Schnetzler,M Neuner,A Reif,S. Kittel-Schneider,S. Schreck,C. Ziegler,L. Weißflog,M. Hilscher,R. Schwarz,L. Schnetzler,M. Neuner,A. Reif
DOI: https://doi.org/10.1055/s-0035-1549946
2015-05-26
Pharmacopsychiatry
Abstract:INTRODUCTION: Disturbances of circadian rhythms occur in all episodes of bipolar disorder (BD). Lithium, as gold-standard in the maintenance treatment of BD, is known to influence circadian processes.METHODS: In a pilot study lymphoblastoid cell lines (LCLs) were generated from 8 BD patients and 6 healthy controls. The LCLs were treated with lithiumchloride (LiCl) for 3 weeks. Cell cycles were then synchronized and expressional analysis by quantitative Real Time PCR was done.RESULTS: BD and controls differed in the period length regarding DBP (albumin D-box binding protein) expression and DBP expression was also influenced by lithium treatment. Furthermore, baseline DBP expression was significantly different between non-treated BD and healthy controls. None of the other analyzed circadian genes showed to be influenced by chronic lithium treatment or to be differentially regulated due to the diagnosis.DISCUSSION: We here show that chronic lithium treatment of LCLs leads to decreased expression of the clock gene DBP, rendering DBP a lithium-regulated gene. We could confirm the role of the circadian clock as well in lithium mode of action as in the pathomechanisms of BD although future studies with a greater number of participants and cell lines are needed.
pharmacology & pharmacy,psychiatry
What problem does this paper attempt to address?